Table 2.
Clinical scores of patients with VAP and non-VAP subjects.
| Characteristics | VAP (n = 30) | Non-VAP (n = 12) | p Value |
|---|---|---|---|
| Non-specifically for VAP | |||
| APACH II | 22.83 ± 1.29 | 14.00 ± 1.35 | 0.00 |
| SAPS II | 55.57 ± 3.27 | 25.50 ± 2.34 | 0.00 |
| ODIN scores | 3.60 ± 0.23 | 1.17 ± 0.11 | 0.00 |
| SOFA scores | 11.27 ± 0.81 | 4.00 ± 0.33 | 0.00 |
| Comorbidity | 6.23 ± 0.48 | 3.92 ± 0.66 | 0.01 |
| Specifically for VAP | |||
| CPIS | 6.40 ± 0.27 | 1.58 ± 0.26 | 0.00 |
| PIRO scores | 2.07 ± 0.18 | 0.83 ± 0.11 | 0.00 |
| IBMP-10 scores | 3.20 ± 0.19 | 0.00 ± 0.00 | 0.00 |
Acute Physiology and Chronic Health Evaluation II (APACH II); SAPS II, simplified acute physiology score II; ODIN, organ dysfunctions and/or infection; SOFA, Sequential Organ Failure Assessment score; CPIS, Clinical Pulmonary Infection Score; continuous variables as mean ± SE, p value < 0.05 was considered significant.